Accelerate Diagnostics | AXDX - 当期純利益



当期純利益 変化する 日付
Abbott USD 1.78B 132M 2025-12
Becton, Dickinson and Co. USD 382M 111M 2025-12
Bio-Rad Laboratories USD -341.9M 659.7M 2025-09
Bruker USD 26M 88.4M 2025-12
Danaher USD 1.2B 289M 2025-12
Hologic USD 179.1M 8.2M 2025-12
Illumina USD 334M 184M 2025-12
Myriad Genetics USD -7.9M 19.5M 2025-12
Pacific Biosciences Of California USD -40.37M 2.37M 2025-12
Quidel USD -733M 477.6M 2025-09
Revvity USD 98.36M 51.71M 2025-12
Thermo Fisher Scientific USD 1.96B 348M 2025-12